The picture depicts a grim scene – a derelict room in a clinic furnished by a cot and a bucket; a blood splatter on the floor. The blood, from an Ebola patient’s gastrointestinal hemorrhage, was there for days after that patient’s death, Rob Fowler said today during an IDWeek presentation. Fowler showed the picture and […]
Remember “3 by 5,” the World Health Organization articulated goal of getting life-saving antiretroviral treatment to three million people in low-and-middle income countries by 2005? It became “3 by 7” — 2007 before treatment available in wealthy countries since the mid-1990s fell within the reach of those three million less fortunate people. But the goal, […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]